We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




SNP Genotyping Platform Accurately Identifies Rare Donor Blood Types

By Labmedica staff writers
Posted on 10 Jul 2008
A single nucleotide polymorphism (SNP) genotyping platform enables faster screening for accurate identification of rare donor blood types. More...


There are many antigens located on the outer surface of the erythrocyte. Combinations of these blood group antigens vary between individuals even within the same A, B, or O blood type. The specificity of the antibodies in a recipient's blood and the prevalence of antigens in the donor population complicate the task of locating appropriate donors.

The OpenArray SNP genotyping platform, based on through-hole nanoliter fluidics technology, allows scientists to conduct up to 3,072 independent polymerase chain reaction (PCR) analyses simultaneously on a thin metal plate the size of a microscope slide. Developed by BioTrove (Woburn, MA, USA) the genotyping platform expands the capabilities of PCR.

BioTrove Inc. and BloodCenter of Wisconsin (Milwaukee, WI, USA) are collaborating to develop single SNP genotyping as a screening tool for identification of better-matched blood for transfusion. They will use the BioTrove OpenArray system to conduct erythrocyte genotyping more quickly and more economically. BloodCenter of Wisconsin will be able to stratify blood donors based on genotypic characteristics, improving the speed and accuracy of blood transfusions for patients in need.

BloodCenter's diagnostic laboratories develop and perform highly specialized tests on patient samples from throughout the United States and the world. The specialized testing and medical consultation provided by the diagnostic laboratories benefit patients in need of bone marrow or organ transplants, patients with bleeding and clotting disorders, and patients with immunologic, neoplastic, or genetic diseases.


Related Links:
BioTrove
BloodCenter of Wisconsin

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.